...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids
【24h】

Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids

机译:合成和发现新型抗癌干细胞衍生自天然三萜酸的化合物

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer stem cells (CSCs) have been reported to be involved in tumorigenesis, tumor recurrence, cancer invasion, metastasis, and drug-resistance. Therefore, the development of drug molecules targeting CSCs has become an attractive therapeutic approach. However, the molecules which can selectively ablate CSCs are extremely rare. To explore the leading compounds targeting CSCs, 52 analogues of triterpenoic acids were synthesized in this study, whose biological activities were evaluated. On the basis of the results of tumorsphere assay, two compounds 48 and 51, derived from oleanolic acid, exhibited suppressive effect on elimination of different type of CSCs. Meanwhile, compounds 48 and 51 could significantly inhibit the growth of several tumors both in vitro and in vivo. Furthermore, treatment of cancer cells with both of two compounds would dramatically increase the level of ROS, which might eliminate the CSCs. Collectively, the leading compounds 48 and 51 were promising anti-CSCs agents that merited further validation as a novel class of chemotherapeutics.
机译:据报道,癌症干细胞(CSCs)涉及肿瘤发生,肿瘤复发,癌症侵袭,转移和耐药性。因此,靶向CSCs的药物分子的发展已成为一种有吸引力的治疗方法。然而,可以选择性消融CSCs的分子非常罕见。为了探讨靶向CSC的前导化合物,在该研究中合成了52种三萜酸的类似物,评估了其生物活性。基于肿瘤术的结果,来自奥沙尔醇酸的两个化合物48和51,对消除不同类型的CSCs表现出抑制作用。同时,化合物48和51可以显着抑制体外和体内几种肿瘤的生长。此外,用两种化合物两种化合物治疗癌细胞将大大增加ROS的水平,这可能消除CSCs。总的来说,前导化合物48和51是有前途的抗CSCS试剂,其将进一步验证作为一种新型化学治疗剂。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2018年第23期|共20页
  • 作者单位

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Tianjin Int Joint Acad Biomed Tianjin Key Lab Mol Drug Res Tianjin 300457 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

    Nankai Univ Coll Pharm State Key Lab Med Chem Biol Tianjin 300071 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号